A Positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis

Cancer Cell

Volumn 25, Issue 5, 2014, Pages 605-620

  Su, Shicheng ^a   Liu, Qiang ^a   Chen, Jingqi ^a,b   Chen, Jianing ^a   Chen, Fei ^a   He, Chonghua ^a   Huang, Di ^a   Wu, Wei ^a   Lin, Ling ^c   Huang, Wei ^a   Zhang, Jin ^d   Cui, Xiuying ^a   Zheng, Fang ^a   Li, Haiyan ^a   Yao, Herui ^a   Su, Fengxi ^a   Song, Erwei ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^d TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; OXAMIC ACID;

ARTICLE; BREAST METASTASIS; CANCER CELL; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPITHELIAL MESENCHYMAL TRANSITION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MACROPHAGE; MAJOR CLINICAL STUDY; MESENCHYME CELL; MOUSE; NONHUMAN; PHENOTYPE; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CHEMOKINES, CC; EPITHELIAL-MESENCHYMAL TRANSITION; FEEDBACK, PHYSIOLOGICAL; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MACROPHAGES; MCF-7 CELLS; MESODERM; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION;

EID: 84900335537     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2014.03.021     Document Type: Article

References (48)

1. Allavena P., Sica A., Solinas G., Porta C., Mantovani A. The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit. Rev. Oncol. Hematol. 2008, 66:1-9.
2. Barnes P.J., Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N.Engl. J. Med. 1997, 336:1066-1071.
3. Biswas S.K., Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 2010, 11:889-896.
4. Bronte V., Chappell D.B., Apolloni E., Cabrelle A., Wang M., Hwu P., Restifo N.P. Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ Tcell responses by dysregulating antigen-presenting cell maturation. J.Immunol. 1999, 162:5728-5737.
5. Chen Q., Khoury M., Chen J. Expression of human cytokines dramatically improves reconstitution of specific human-blood lineage cells in humanized mice. Proc. Natl. Acad. Sci. U S A 2009, 106:21783-21788.
6. Chen J., Yao Y., Gong C., Yu F., Su S., Liu B., Deng H., Wang F., Lin L., Yao H., et al. CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. Cancer Cell 2011, 19:541-555.
7. Christofori G. New signals from the invasive front. Nature 2006, 441:444-450.
8. Condeelis J., Pollard J.W. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006, 124:263-266.
9. Dangaj D., Abbott K.L., Mookerjee A., Zhao A., Kirby P.S., Sandaltzopoulos R., Powell D.J., Lamazière A., Siegel D.L., Wolf C., Scholler N. Mannose receptor (MR) engagement by mesothelin GPI anchor polarizes tumor-associated macrophages and is blocked by anti-MR human recombinant antibody. PLoS ONE 2011, 6:e28386.
10. DeNardo D.G., Barreto J.B., Andreu P., Vasquez L., Tawfik D., Kolhatkar N., Coussens L.M. CD4(+) Tcells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 2009, 16:91-102.
11. Dranoff G. GM-CSF-based cancer vaccines. Immunol. Rev. 2002, 188:147-154.
12. Faries M.B., Hsueh E.C., Ye X., Hoban M., Morton D.L. Effect of granulocyte/macrophage colony-stimulating factor on vaccination with an allogeneic whole-cell melanoma vaccine. Clin. Cancer Res. 2009, 15:7029-7035.
13. Filipazzi P., Valenti R., Huber V., Pilla L., Canese P., Iero M., Castelli C., Mariani L., Parmiani G., Rivoltini L. Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine. J.Clin. Oncol. 2007, 25:2546-2553.
14. Francí C., Takkunen M., Dave N., Alameda F., Gómez S., Rodríguez R., Escrivà M., Montserrat-Sentís B., Baró T., Garrido M., et al. Expression of Snail protein in tumor-stroma interface. Oncogene 2006, 25:5134-5144.
15. Goswami S., Sahai E., Wyckoff J.B., Cammer M., Cox D., Pixley F.J., Stanley E.R., Segall J.E., Condeelis J.S. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res. 2005, 65:5278-5283.
16. Guttilla I.K., Phoenix K.N., Hong X., Tirnauer J.S., Claffey K.P., White B.A. Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs. Breast Cancer Res. Treat. 2012, 132:75-85.
17. Hamilton J.A. GM-CSF in inflammation and autoimmunity. Trends Immunol. 2002, 23:403-408.
18. Hamilton J.A. Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 2008, 8:533-544.
19. Hernandez L., Smirnova T., Kedrin D., Wyckoff J., Zhu L., Stanley E.R., Cox D., Muller W.J., Pollard J.W., Van Rooijen N., Segall J.E. The EGF/CSF-1 paracrine invasion loop can be triggered by heregulin beta1 and CXCL12. Cancer Res. 2009, 69:3221-3227.
20. Hirschhaeuser F., Sattler U.G., Mueller-Klieser W. Lactate: a metabolic key player in cancer. Cancer Res. 2011, 71:6921-6925.
21. Holt N., Wang J., Kim K., Friedman G., Wang X., Taupin V., Crooks G.M., Kohn D.B., Gregory P.D., Holmes M.C., Cannon P.M. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 invivo. Nat. Biotechnol. 2010, 28:839-847.
22. Ito R., Takahashi T., Katano I., Ito M. Current advances in humanized mouse models. Cell. Mol. Immunol. 2012, 9:208-214.
23. Jinquan T., Frydenberg J., Mukaida N., Bonde J., Larsen C.G., Matsushima K., Thestrup-Pedersen K. Recombinant human growth-regulated oncogene-alpha induces T lymphocyte chemotaxis. A process regulated via IL-8 receptors by IFN-gamma, TNF-alpha, IL-4, IL-10, and IL-13. J.Immunol. 1995, 155:5359-5368.
24. Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 2009, 9:239-252.
25. Julien S., Puig I., Caretti E., Bonaventure J., Nelles L., van Roy F., Dargemont C., de Herreros A.G., Bellacosa A., Larue L. Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene 2007, 26:7445-7456.
26. Kuang D.M., Wu Y., Chen N., Cheng J., Zhuang S.M., Zheng L. Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes. Blood 2007, 110:587-595.
27. Kudo-Saito C., Shirako H., Takeuchi T., Kawakami Y. Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell 2009, 15:195-206.
28. Lin Y., Huang R., Chen L., Li S., Shi Q., Jordan C., Huang R.P. Identification of interleukin-8 as estrogen receptor-regulated factor involved in breast cancer invasion and angiogenesis by protein arrays. Int. J. Cancer 2004, 109:507-515.
29. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., Brooks M., Reinhard F., Zhang C.C., Shipitsin M., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
30. Marigo I., Bosio E., Solito S., Mesa C., Fernandez A., Dolcetti L., Ugel S., Sonda N., Bicciato S., Falisi E., et al. Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity 2010, 32:790-802.
31. Martinez F.O., Helming L., Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol. 2009, 27:451-483.
32. Mizukami Y., Kono K., Kawaguchi Y., Akaike H., Kamimura K., Sugai H., Fujii H. CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory Tcells in gastric cancer. Int. J. Cancer 2008, 122:2286-2293.
33. Oskarsson T., Acharyya S., Zhang X.H., Vanharanta S., Tavazoie S.F., Morris P.G., Downey R.J., Manova-Todorova K., Brogi E., Massagué J. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat. Med. 2011, 17:867-874.
34. Park B.K., Zhang H., Zeng Q., Dai J., Keller E.T., Giordano T., Gu K., Shah V., Pei L., Zarbo R.J., et al. NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nat. Med. 2007, 13:62-69.
35. Parmiani G., Castelli C., Pilla L., Santinami M., Colombo M.P., Rivoltini L. Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients. Ann. Oncol. 2007, 18:226-232.
36. Patsialou A., Wyckoff J., Wang Y., Goswami S., Stanley E.R., Condeelis J.S. Invasion of human breast cancer cells invivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor. Cancer Res. 2009, 69:9498-9506.
37. Pollard J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 2004, 4:71-78.
38. Qian B.Z., Li J., Zhang H., Kitamura T., Zhang J., Campion L.R., Kaiser E.A., Snyder L.A., Pollard J.W. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 2011, 475:222-225.
39. Serafini P., Carbley R., Noonan K.A., Tan G., Bronte V., Borrello I. High-dose granulocyte-macrophage colony-stimulating factor-producingvaccines impair the immune response through the recruitment of myeloid suppressor cells. Cancer Res. 2004, 64:6337-6343.
40. Slingluff C.L., Petroni G.R., Olson W.C., Smolkin M.E., Ross M.I., Haas N.B., Grosh W.W., Boisvert M.E., Kirkwood J.M., Chianese-Bullock K.A. Effect of granulocyte/macrophage colony-stimulating factor on circulating CD8+ and CD4+ T-cell responses to a multipeptide melanoma vaccine: outcome of a multicenter randomized trial. Clin. Cancer Res. 2009, 15:7036-7044.
41. Solinas G., Schiarea S., Liguori M., Fabbri M., Pesce S., Zammataro L., Pasqualini F., Nebuloni M., Chiabrando C., Mantovani A., Allavena P. Tumor-conditioned macrophages secrete migration-stimulating factor:a new marker for M2-polarization, influencing tumor cell motility. J.Immunol. 2010, 185:642-652.
42. Takeda K., Hatakeyama K., Tsuchiya Y., Rikiishi H., Kumagai K. A correlation between GM-CSF gene expression and metastases in murine tumors. Int. J. Cancer 1991, 47:413-420.
43. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002, 2:442-454.
44. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
45. Tsuchiya Y., Igarashi M., Suzuki R., Kumagai K. Production of colony-stimulating factor by tumor cells and the factor-mediated induction of suppressor cells. J.Immunol. 1988, 141:699-708.
46. Wang X., Qi Z., Wei H., Tian Z., Sun R. Characterization of human B cells in umbilical cord blood-transplanted NOD/SCID mice. Transpl. Immunol. 2012, 26:156-162.
47. Wyckoff J., Wang W., Lin E.Y., Wang Y., Pixley F., Stanley E.R., Graf T., Pollard J.W., Segall J., Condeelis J. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res. 2004, 64:7022-7029.
48. Zhang B., Yin C., Li H., Shi L., Liu N., Sun Y., Lu S., Liu Y., Sun L., Li X., et al. Nir1 promotes invasion of breast cancer cells by binding to chemokine (C-C motif) ligand 18 through the PI3K/Akt/GSK3β/Snail signalling pathway. Eur. J. Cancer 2013, 49:3900-3913.